Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-02-06

Clinical Trial Update: Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6 [NA]

View source ↗

Summary

The document notes a recruiting clinical trial evaluating toripalimab plus actinomycin-D as first-line treatment for gestational trophoblastic neoplasia with FI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Actinomycin D (dactinomycin)
  • Toripalimab (Toripalimab)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Gestational Trophoblastic Neoplasia | NA | Status: RECRUITING